Yes the outstanding shares have increased because
Post# of 36537
(Total Views: 331)
Posted On: 10/29/2020 10:21:01 AM
Yes the outstanding shares have increased because of financing. What’s done is done. Can’t change the past. We can look at the future realistically. Either NGIO is a complete flop or it is successful. I’ll assume the positive.
NGIO
PPS (guess): $5
GNBT
Pre-financing shares: 75m
Final share count: 110m
NGIO shares held: 300m
NGIO share value: 1500m (at $5)
GNBT share value holding NGIO shares
Pre-financing: $20 per share
Post financing: $13.63 per share
Yes, using this calculation, $6.37 per share was lost to financing, but
No share increase no financing
No financing no peptides
No peptides no vaccine
No vaccine no deals
No deals maybe no IPO
Once NGIO is on NASDAQ, you can’t have the GNBT PPS value at .20. If an individual owned 300m NGIO shares ($1.5 billion) would anyone claim they were worth only $60 million (.20 x 300m shares)?
NGIO
PPS (guess): $5
GNBT
Pre-financing shares: 75m
Final share count: 110m
NGIO shares held: 300m
NGIO share value: 1500m (at $5)
GNBT share value holding NGIO shares
Pre-financing: $20 per share
Post financing: $13.63 per share
Yes, using this calculation, $6.37 per share was lost to financing, but
No share increase no financing
No financing no peptides
No peptides no vaccine
No vaccine no deals
No deals maybe no IPO
Once NGIO is on NASDAQ, you can’t have the GNBT PPS value at .20. If an individual owned 300m NGIO shares ($1.5 billion) would anyone claim they were worth only $60 million (.20 x 300m shares)?
(1)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼